Bashir Endovascular Catheter
Payments companies reported to CMS as associated with Bashir Endovascular Catheter. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Bashir Endovascular Catheter, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Bashir Endovascular Catheter
These are the largest totals companies reported as associated with Bashir Endovascular Catheter. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Pete Fong | Nashville, TN | Cardiovascular Disease | $766.32 |
| Eric Gnall | Wynnewood, PA | Interventional Cardiology | $540.00 |
| Jorge Magallon | San Antonio, TX | Interventional Cardiology | $532.96 |
| Barry Bertolet | Tupelo, MS | Cardiovascular Disease | $486.28 |
| Michael Levy | Burlington, MA | Interventional Cardiology | $407.52 |
| Alexander Sullivan | Nashville, TN | Interventional Cardiology | $405.22 |
| Jay Patel | Nashville, TN | Interventional Cardiology | $405.22 |
| Roger Williams | Tupelo, MS | Interventional Cardiology | $401.71 |
| Lawrence Calabrese | Liverpool, NY | Diagnostic Radiology | $368.46 |
| Rajesh Mallela | Kokomo, IN | Interventional Cardiology | $319.74 |
Prescribed Bashir Endovascular Catheter?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.